Attempts to produce in animals disease equivalent to the chronic obstructive airway disease of man have met with little success. Experimental approaches have usually focussed on single etiological mechanisms, e.g. chronic hypoxia, chronic inflammation, or antigen-antibody reactions.' Such studies, by deliberate design, have excluded multiple or synergistic factors acting in concert.
Infection or, more specifically, infectious bronchitis is widely believed to be a major factor in the obstructive respiratory disease syndrome and the acute exacerbations which punctuate its course.t' Yet in our studies of this disease, lower respiratory tract secretions collected during acute exacerbations by transtracheal or laryngeal puncture have proved to be bacteriologically sterile in one third of our patients and to contain no demonstrable viral agent.84 Therefore, infectious factors were not of vital significance in this group of patients, at least during the time that they were studied.
In this presentation I wish to make two points. First, I want to highlight some of the analogies that exist between chronic obstructive respiratory disease and another clinical enigma, chronic pyelonephritis. Second, based on our studies of experimental pyelonephritis I wish to underline the importance of infectious and immune factors in tissue injury and to suggest that both may be critical factors in devising model systems of chronic obstructive respiratory disease.
Analogies between chronic lung disease and chronic pyelonephritis As indicated in Table 1 , both the lung and the kidney are "extracorporeal" organ systems. Each is in continual contact with the outside bac- t Factors other than infection may well be of additional major importance. Emphysema is not invariably accompanied by chronic bronchitis and all cases of chronic bronchitis are not associated with emphysema. Yet in the bulk of patients with chronic obstructive airway disease, infectious bronchitis is a common finding. It is this large group of patients that the author has in mind in preparing this discussion. teria-laden world and periodic infection is a common occurrence. Both the lung and the kidney possess organ-specific antigenic constituents."-7 Antibodies reactive with lung or sputum have been reported in patients with chronic pulmonary disease.8" Antibodies directed against kidney have also been demonstrated in animals and man with renal disease.lOU
Both diseases (Table 1 ) follow a progressive course interrupted by acute exacerbations. Some of these exacerbations are associated with pathogenic bacteria in the sputum or urine. In other exacerbations, even in the same patient, cultures of the sputum or urine may be sterile." Lung or kidney tissue, secured by biopsy or at autopsy, may also prove to be free of bacteria.
Finally, in neither chronic obstructive respiratory disease nor chronic pyelonephritis is there a pathologic hallmark identifying one pathogenetic mechanism over another. Histologic changes considered characteristic of each disease may be induced by a variety of mechanisms. For example, morphologic features of pyelonephritis may be induced by infection or vascular occlusion or obstruction to urine flow."8' Even "thyroidization" may not be a unique and invariable microscopic finding associated with infection of the kidney. The same situation exists with respect to the lung, changes of chronic obstructive lung disease having been produced by such different procedures as capillary obliteration and prolonged, repeated exposure to sulfur dioxide."1" Indeed, in both chronic lung disease and pyelonephritis, diagnosis usually rests on demonstrated physiologic malfunctions in contrast to physical or anatomic abnormalities.
Experimental pyelonephritis in rats
Pyelonephritis has been under study in our laboratories using a model system of rats infected with staphylococci.18 In our work we have focussed on excretion of beta-glucuronidase in the urine as a means of monitoring renal cell injury."7'8 A major stimulus for this experimental approach was the report that measurement of urinary beta-glucuronidase might be a promising means for detection of chronic pyelonephritis in man.'9 Rat renal tubule cells contain large amounts of this enzyme as well as other hydrolytic enzymes. Damage to these cells, either by staphylococcal infection or mercury, results in increased excretion of beta-glucuronidase in the urine."'T" Experimental staphylococcal pyelonephritis in rats is associated with increased urinary excretion of beta-glucuronidase. Two patterns of enzyme excretion are observed. In some rats, illustrated in Figure 1 , beta-glucuronidase excretion rises precipitously about four days after staphylococcal infection, remains elevated for two or three days, returns to normal preinfection levels and stays at pre-infection levels. Rise in enzyme is accompanied by intense pyuria and heavy bacteriuria. Figure 2 . Urine beta-glucuronidase excretion again rises rapidly, reaches peak values by the 4th day after infection and returns toward baseline values by the 8th day. Initial rise in enzyme again is associated with appearance of pyuria and bacteriuria. Fall in enzyme to baseline values is associated with disappearance of pyuria.* About two weeks after infection, a second rise and fall in urine glucuronidase occurs. This second wave in enzyme excretion is not associated sith pyuria. In some animals, urine and kidneys contain no viable staphylococci.
* Accurate information about viable bacteria in urine requires culture of urine obtained by bladder puncture at time animals are sacrificed. Since rats represented by data in Figure 2 were not sacrificed until 20 or more days post-infection, precise information regarding presence and number of viable staphylococci in urine at the time initially elevated enzyme values returned to baseline, i.e. 8-12 days, is not available. Based on preliminary data obtained from our studies, two lines of evidence suggest that the second enzyme excretion peak in some animals may represent continued or recurrent renal injury having an immunologic rather than an infectious basis. First, cyclophosphamide, a potent immunologic suppressive agent, in a dose known to abolish both circulating antibody and cell-mediated immune responses, diminishes the second enzyme excretion peak. Second, work in progress suggests that transfer of lymphoid cells from donor rats sensitized to staphylococci into recipients that have recovered from staphylococcal pyelonephritis elicits a prompt increased excretion of urinary beta-glucuronidase.
Postulated synergistic effects of infectious and immune factors in tissue injury
These observations suggest that pyelonephritis in its subacute or chronic forms involves both infectious factors and immune responses which act in concert to induce and/or perpetuate kidney damage.
The sequence of events we visualize taking place in the kidney is shown schematically in Figure 3 eliminates viable bacteria. Local and/or systemic immune responses against the infecting bacteria result in antigen-"sensitized cell" interactions at sites of antigen deposition. Further inflammation and additional cell injury occurs. Persisting viable bacteria might well set off subsequent waves of infection and elicit additional cycles of antigen-immune response interaction. With time, progressive impairment in renal function would lead to clinical manifestations of chronic pyelonephritis at which time the urine and, indeed, the kidney itself, might well contain no viable bacteria.
The sequence of events in Figure 3 is equivalent biologically to rejection by a host of his own (autologous) kidney. It is of interest that one type of renal transplant rejection pattern observed by the Paris group simulates chronic pyelonephritis histologically and is so-classified.' The production of a localized graft-versus-host reaction in the kidney, induced by subcapsular injection of allogeneic lymphocytes, gives rise to an inflammatory reaction with a striking resemblance to pyelonephritis.' This latter finding by Elkins' plus evidence that circulating antibodies against gram-negative bacillary antigens may decrease, rather than increase, incidence or severity of experimental pyelonephritis in rats," and our own strong interests in cell-mediated immune responses, explain why "sensitized cells" or "sensitized lymphocytes" rather than conventional antibody is selected as the type of immune response of importance in the events set out in Figure 3 .
If one substituted bronchial epithelial cells for renal tubule cells in Figure  3 , the events depicted might well culminate in chronic bronchial cell injury and inflammation, resistance to air outflow and the physiologic-anatomic consequences which collectively comprise the chronic obstructive respiratory syndrome. The theory is amenable to test; essential materials are at hand.
SUMMARY
In this brief and speculative discussion, analogies between chronic obstructive respiratory disease and chronic pyelonephritis have been examnined and observations concerning experimental pyelonephritis in rats presented. A picture of infectious and immune factors acting in concert to perpetuate cell injury emerges. The concepts may prove useful in devising better experimental animal model systems of obstructive airway disease, desirable and much needed tools in attacking the problem of chronic lung disease of man.
